Eleme Medical
Aesthetics company developing proprietary technology for all areas of body shaping.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
$2.5m Valuation: $2.5m | Acquisition | ||
| Total Funding | 000k | ||
Eleme Medical, founded in 1996, operates within the therapeutic devices industry, specializing in the development of laser-based technologies for aesthetic treatments. The company's core business revolves around providing medical devices for body shaping, skin tightening, and the temporary reduction of cellulite.
The company's technology portfolio includes Photomology®, a proprietary system designed for the temporary improvement in the appearance of cellulite. Additionally, Eleme Medical developed a device for laser-assisted lipolysis, a procedure used for contouring and firming localized areas of the body. This positions the company in the non-invasive and minimally invasive cosmetic procedure market, catering to clients seeking aesthetic enhancements without major surgery.
The company successfully raised $48.1 million in funding to support its research, development, and commercialization efforts. Its investor base included venture capital firms such as EDF Ventures, L Capital Partners, Pinnacle Ventures, Three Arch Partners, and asset manager Tekla Capital Management. This financial backing enabled the company to advance its laser techniques and treatment protocols. A significant milestone in the company's history was its acquisition by Cynosure, a firm specializing in other medical devices and supplies, on February 3, 2011.
Keywords: therapeutic devices, aesthetic medicine, laser lipolysis, cellulite reduction, skin tightening, body contouring, Photomology, medical technology, non-invasive procedures, cosmetic treatments, medical lasers, aesthetic devices, dermatology, plastic surgery, private equity, venture capital, medical device manufacturing, Cynosure acquisition, aesthetic technology, body shaping